Back to Search Start Over

Extended duration of letermovir prophylaxis: how long is long enough?

Authors :
Douglas AP
Slavin MA
Source :
The Lancet. Haematology [Lancet Haematol] 2024 Feb; Vol. 11 (2), pp. e88-e90. Date of Electronic Publication: 2023 Dec 21.
Publication Year :
2024

Abstract

Competing Interests: APD has received honoraria paid to her institution from Gilead Sciences. MAS has received grants to her institution from F2G and Merck, honoraria paid to her institution by Shionogi, and participated on the data safety monitoring board of trials by Roche and Pfizer.

Subjects

Subjects :
Humans
Acetates
Quinazolines
Antiviral Agents therapeutic use
Hematopoietic Stem Cell Transplantation

Details

Language :
English
ISSN :
2352-3026
Volume :
11
Issue :
2
Database :
MEDLINE
Journal :
The Lancet. Haematology
Publication Type :
Academic Journal
Accession number :
38142694
Full Text :
https://doi.org/10.1016/S2352-3026(23)00368-X
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details